[go: up one dir, main page]

AU2002311482A1 - Treatment and prevention of lipodermatosclerosis - Google Patents

Treatment and prevention of lipodermatosclerosis

Info

Publication number
AU2002311482A1
AU2002311482A1 AU2002311482A AU2002311482A AU2002311482A1 AU 2002311482 A1 AU2002311482 A1 AU 2002311482A1 AU 2002311482 A AU2002311482 A AU 2002311482A AU 2002311482 A AU2002311482 A AU 2002311482A AU 2002311482 A1 AU2002311482 A1 AU 2002311482A1
Authority
AU
Australia
Prior art keywords
lipodermatosclerosis
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002311482A
Inventor
Sarah Elizabeth Herrick
Geoffrey John Laurent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Medical Ltd
Original Assignee
Johnson and Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Ltd filed Critical Johnson and Johnson Medical Ltd
Publication of AU2002311482A1 publication Critical patent/AU2002311482A1/en
Abandoned legal-status Critical Current

Links

AU2002311482A 2001-06-27 2002-06-26 Treatment and prevention of lipodermatosclerosis Abandoned AU2002311482A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0115707.2 2001-06-27

Publications (1)

Publication Number Publication Date
AU2002311482A1 true AU2002311482A1 (en) 2003-03-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002364364A1 (en) Method of treating apoptosis and compositions thereof
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2002314466A1 (en) Withasol and methods of use
AU2002335085A1 (en) Angiopoietins and methods of use thereof
AU2003209851A1 (en) Method of treatment and/or prophylaxis
AU2002359747A1 (en) Prevention and treatment of atherosclerosis and restenosis
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU2002364171A1 (en) Materials and methods for the treatment or prevention of obesity
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2003231279A1 (en) Prevention and treatment of type 2 diabetes
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU3735900A (en) Methods of treatment and prevention of restenosis
AU2002311482A1 (en) Treatment and prevention of lipodermatosclerosis
AUPR626001A0 (en) A method of treatment and/or prophylaxis
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
AU2002353823A1 (en) Detection and treatment of intravascular lesions
WO2003016502A9 (en) Tramdorins and methods of using tramdorins
AU2335601A (en) Treatment or prevention of diarrhea
AUPR611401A0 (en) A method of treatment and/or prophylaxis
AUPR434501A0 (en) Composition and method of treatment
AU2002323560A1 (en) Method for the treatment and prevention of cachexia
AUPR592601A0 (en) Treatment of restenosis